Literature DB >> 10183010

Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.

L M Lamers1.   

Abstract

In many countries market-oriented health care reforms are high on the political agenda. A common element of these reforms is that the consumers may choose among competing health insurers or health plans, which are largely financed through premium-replacing capitation payments. Since 1993, Dutch sickness funds receive risk-adjusted capitation payments based on demographic factors. It has been shown that the predictive accuracy of a demographic capitation model improves when it is extended with diagnostic information from prior hospitalizations, in the form of Diagnostic Costs Groups (DCGs). In this study a DCG classification is developed using Dutch cost data of sickness fund members of all ages. The study also dealt with the question of how to handle high discretion diagnoses. For the Dutch situation high discretion diagnoses may be defined as those diagnoses for which day case treatment is a possible alternative for a hospital admission. Grouping persons with a hospital admission for high discretion diagnoses together with people without an admission resulted in a slight reduction of the predictive accuracy of the DCG model. Adequate risk-adjustment is critical to the success of market-oriented health care reforms. The use of diagnostic information from prior hospitalizations seems a promising option for improving the capitation formula.

Entities:  

Mesh:

Year:  1998        PMID: 10183010     DOI: 10.1016/s0168-8510(98)00031-1

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  10 in total

1.  Ignoring small predictable profits and losses: a new approach for measuring incentives for cream skimming.

Authors:  E M van Barneveld; L M Lamers; R C van Vliet; W P van de Ven
Journal:  Health Care Manag Sci       Date:  2000-02

2.  Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data.

Authors:  René C J A van Vliet
Journal:  Int J Health Care Finance Econ       Date:  2004-12

3.  Overpaying morbidity adjusters in risk equalization models.

Authors:  R C van Kleef; R C J A van Vliet; W P M M van de Ven
Journal:  Eur J Health Econ       Date:  2015-09-29

4.  Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.

Authors:  Naomi C Sacks; James F Burgess; Howard J Cabral; Steven D Pizer; Marie E McDonnell
Journal:  J Gen Intern Med       Date:  2013-02-13       Impact factor: 5.128

5.  The Comparison of Matching Methods Using Different Measures of Balance: Benefits and Risks Exemplified within a Study to Evaluate the Effects of German Disease Management Programs on Long-Term Outcomes of Patients with Type 2 Diabetes.

Authors:  Birgit Fullerton; Boris Pöhlmann; Robert Krohn; John L Adams; Ferdinand M Gerlach; Antje Erler
Journal:  Health Serv Res       Date:  2016-02-03       Impact factor: 3.402

6.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.

Authors:  Carola A Huber; Thomas D Szucs; Roland Rapold; Oliver Reich
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

7.  A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems.

Authors:  Christin Juhnke; Susanne Bethge; Axel C Mühlbacher
Journal:  Int J Integr Care       Date:  2016-10-26       Impact factor: 5.120

8.  Improving risk equalization using information on physiotherapy diagnoses.

Authors:  Frank Eijkenaar; René C J A van Vliet
Journal:  Eur J Health Econ       Date:  2017-02-09

9.  Can universal access and competition in long-term care insurance be combined?

Authors:  Pieter Bakx; Frederik Schut; Eddy van Doorslaer
Journal:  Int J Health Econ Manag       Date:  2015-01-30

10.  'Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial.

Authors:  Katharina Tabea Jungo; Zsofia Rozsnyai; Sophie Mantelli; Carmen Floriani; Axel Lennart Löwe; Fanny Lindemann; Nathalie Schwab; Rahel Meier; Lamia Elloumi; Corlina Johanna Alida Huibers; Bastiaan Theodoor Gerard Marie Sallevelt; Michiel C Meulendijk; Emily Reeve; Martin Feller; Claudio Schneider; Heinz Bhend; Pius M Bürki; S Trelle; Marco Spruit; Matthias Schwenkglenks; Nicolas Rodondi; Sven Streit
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.